Stock RMAH FARMACEUTICA REMEDIA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Farmaceutica REMEDIA S.A.

Equities

RMAH

RORMAHACNOR2

Drug Retailers

End-of-day quote Bucharest S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.704 RON +0.28% Intraday chart for Farmaceutica REMEDIA S.A. +2.03% +4.30%
Feb. 27 Farmaceutica REMEDIA S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Farmaceutica REMEDIA S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 36.39 44.43 38.51 67.71 66.44 56.16
Enterprise Value (EV) 1 26.46 40.96 30.05 34.22 43.56 39.27
P/E ratio 9.69 x 14.6 x 15.8 x 1.78 x 9.21 x 9.7 x
Yield - - - 23.4% 7.16% 8.47%
Capitalization / Revenue 0.1 x 0.1 x 0.09 x 0.15 x 0.14 x 0.1 x
EV / Revenue 0.08 x 0.09 x 0.07 x 0.08 x 0.09 x 0.07 x
EV / EBITDA 7.21 x 15.1 x -58.9 x 9.95 x 4.77 x 3.81 x
EV / FCF -2.44 x -5.37 x 11.9 x -14.2 x 4.22 x 25.6 x
FCF Yield -41.1% -18.6% 8.43% -7.05% 23.7% 3.91%
Price to Book 0.82 x 0.95 x 0.78 x 0.85 x 0.97 x 0.82 x
Nbr of stocks (in thousands) 105,790 105,790 105,790 105,790 95,181 95,181
Reference price 2 0.3440 0.4200 0.3640 0.6400 0.6980 0.5900
Announcement Date 3/20/18 4/25/19 4/15/20 4/15/21 4/20/22 4/22/23
1RON in Million2RON
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 351.2 464 446.4 441.5 477.1 535.9
EBITDA 1 3.672 2.72 -0.5101 3.441 9.137 10.31
EBIT 1 3.014 2.037 -1.161 2.92 8.277 6.434
Operating Margin 0.86% 0.44% -0.26% 0.66% 1.73% 1.2%
Earnings before Tax (EBT) 1 4.724 3.683 3.123 42.77 8.633 7.058
Net income 1 3.765 3.048 2.441 37.77 7.233 5.809
Net margin 1.07% 0.66% 0.55% 8.56% 1.52% 1.08%
EPS 2 0.0355 0.0287 0.0230 0.3600 0.0758 0.0608
Free Cash Flow 1 -10.86 -7.63 2.534 -2.414 10.32 1.535
FCF margin -3.09% -1.64% 0.57% -0.55% 2.16% 0.29%
FCF Conversion (EBITDA) - - - - 112.94% 14.89%
FCF Conversion (Net income) - - 103.81% - 142.66% 26.42%
Dividend per Share - - - 0.1500 0.0500 0.0500
Announcement Date 3/20/18 4/25/19 4/15/20 4/15/21 4/20/22 4/22/23
1RON in Million2RON
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 9.93 3.47 8.46 33.5 22.9 16.9
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -10.9 -7.63 2.53 -2.41 10.3 1.54
ROE (net income / shareholders' equity) 8.81% 6.68% 5.1% 58.6% 9.77% 8.5%
ROA (Net income/ Total Assets) 1.02% 0.51% -0.26% 0.72% 2.09% 1.5%
Assets 1 369.2 596.4 -937.1 5,224 346.4 388.1
Book Value Per Share 2 0.4200 0.4400 0.4600 0.7500 0.7200 0.7200
Cash Flow per Share 2 0.0900 0.0300 0.1000 0.3200 0.2500 0.1900
Capex 1 0.44 0.99 0.8 0.08 0.04 0.04
Capex / Sales 0.12% 0.21% 0.18% 0.02% 0.01% 0.01%
Announcement Date 3/20/18 4/25/19 4/15/20 4/15/21 4/20/22 4/22/23
1RON in Million2RON
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Retail - Drugs without Grocery

1st Jan change Capi.
FARMACEUTICA REMEDIA S.A. Stock Farmaceutica REMEDIA S.A.
+4.30% 14.38M
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-12.86% 8.57B
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+32.95% 1.32B
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
+6.76% 419M
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
+5.93% 282M
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+10.56% 224M
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-8.26% 85.07M
MEDICAL IKKOU GROUP CO.,LTD. Stock Medical Ikkou Group Co.,Ltd.
+20.94% 59.57M
Retail - Drugs without Grocery
  1. Stock Market
  2. Equities
  3. RMAH Stock
  4. Financials Farmaceutica REMEDIA S.A.